Association of FoxP3⁺ T regulatory lymphocytes with epicardial adipose tissue thickness in patients with coronary heart disease

Background. Increase ofthe epicardial adipose tissue (EAT) thickness isassociated with development of inflammation and cardiovascular complications, however, there is no data on the relationship between EAT thickening and the number of immunosuppressive regulatory T lymphocytes.

The aim. To study the number of circulating T regulatory lymphocytes and nuclear translocation ofthe FoxP3 transcription factor in patients with stable coronary heart disease (CHD) depending on the epicardial adipose tissue thickness.

Materials and methods. We examined 30 patients with chronic stable CHD. The EAT thickness was measured by echocardiography. Patients were divided into groups depending on the presence and absence of EAT thickening above 5 mm (groups 1 and 2, respectively). Imaging flow cytometry was used to determine the number of T regulatory lymphocytes and the level of FoxP3 nuclear translocation. The concentration of cytokines and high sensitivity C-reactive protein (hsCRP) was determined using enzyme-linked immunosorbent assay in blood serum.

Results. Anthropometric indicators of obesity and the severity of atherosclerosis were comparable between groups. In group 2, there was an increase in low-density lipoprotein cholesterol concentration (p = 0.043), ratio of low-density lipoprotein cholesterol tohigh-density lipoprotein cholesterol (p = 0.017) and the concentration ofhsCRP (p = 0.044) andIL-1β (p = 0.005), adecrease in the number and relative count of Tregulatory lymphocytes (p = 0.020 andp = 0.026, respectively), aswellas thenumber of cells withFoxP3 nuclear translocation (p = 0.018) compared togroup1. According tomultiple logistic regression, the concentration ofhsCRP, IL-1β and T regulatory lymphocytes relative count in total were the predictors of EAT thickening (accuracy 80 %; sensitivity 75 %; specificity 84,6 %; AUC = 0.89).

Conclusions. Thickening of epicardial adipose tissue inpatients withcoronary heart disease is associated with a decrease in the number of T regulatory lymphocytes andFoxP3 nuclear translocation inthem in presence of comparable anthropometric parameters of obesity and the severity of coronary atherosclerosis.

1. Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022; 19: 593-606. doi: 10.1038/s41569-022-00679-9

2. Davydova AV, Nikiforov VS, Khalimov YuS. Thickness of epicardial adipose tissue as a predictor of cardiovascular risk. Consilium Medicum. 2018; 20(10): 91-94. (In Russ.). doi: 10.26442/2075-1753_2018.10.91-94

3. Blinova NV, Azimova MO, Zhernakova JV, Saidova MA, Ternovoy SK, Zheleznova EA, et al. Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity. Systemic Hypertension. 2020; 17(4): 74-79. (In Russ.). doi: 10.26442/2075082X.2020.4.200557

4. Romantsova TI. Adipose tissue: Colors, depots and functions. Obesity and Metabolism. 2021; 18(3): 282-301. (In Russ.). doi: 10.14341/omet12748

5. Kologrivova IV, Koshelskaya OA, Suslova TE, Vinnitskaya IV, Kravchenko ES, Trubacheva OA. Interplay of inflammation and metabolic factors in comorbid obesity and arterial hypertension of high and very high risk. Russian Journal of Cardiology. 2018; (5): 27-33. (In Russ.). doi: 10.15829/1560-4071-2018-5-27-33

6. Foks AC, Lichtman AH, Kuiper J. Treating atherosclerosis with regulatory T cells. Arterioscler Thromb Vasc Biol. 2015; 35(2): 280-287. doi: 10.1161/ATVBAHA.114.303568

7. Feldhoff LM, Rueda CM, Moreno-Fernandez ME, Sauer J, Jackson CM, Chougnet CA, et al. IL-1β induced HIF-1α inhibits the differentiation of human FOXP3+ T cells. Sci Rep. 2017; 7(1): 465. doi: 10.1038/s41598-017-00508-x

8. Rueda CM, Rodríguez-Perea AL, Moreno-Fernandez M, Jackson CM, Melchior JT, Davidson WS, et al. High density lipoproteins selectively promote the survival of human regulatory T cells. J Lipid Res. 2017; 58(8): 1514-1523. doi: 10.1194/jlr.M072835

9. Wang R, Liu H, He P, An D, Guo X, Zhang X, et al. Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8+ T cells and the exclusion of Treg cells. Front Immunol. 2022; 13: 947756. doi: 10.3389/fimmu.2022.947756

10. Ferreira RC, Simons HZ, Thompson WS, Rainbow DB, Yang X, Cutler AJ, et al. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity. J Autoimmun. 2017; 84: 75-86. doi: 10.1016/j.jaut.2017.07.009

11. Ni X, Kou W, Gu J, Wei P, Wu X, Peng H, et al. TRAF6 directs FOXP3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination. EMBO J. 2019; 38(9): e99766. doi: 10.15252/embj.201899766

12. Zeng Q, Sun X, Xiao L, Xie Z, Bettini M, Deng T. A unique population: Adipose-resident regulatory T cells. Front Immunol. 2018; 9: 2075. doi: 10.3389/fimmu.2018.02075

13. Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, Narula V, et al. Visceral adipose inflammation in obesity is associated with critical alterations in T regulatory cell numbers. PLoS One. 2011; 6(1): e16376. doi: 10.1371/journal.pone.0016376

14. Donninelli G, Del Cornò M, Pierdominici M, Scazzocchio B, Varì R, Varano B, et al. Distinct blood and visceral adipose tissue regulatory T cell and innate lymphocyte profiles characterize obesity and colorectal cancer. Front Immunol. 2017; 8: 643. doi: 10.3389/fimmu.2017.00643

15. Yu Y, Bai H, Wu F, Chen J, Li B, Li Y. Tissue adaptation of regulatory T cells in adipose tissue. Eur J Immunol. 2022; 52(12): 1898-1908. doi: 10.1002/eji.202149527

16. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983; 51(3): 606. doi: 10.1016/S0002-9149(83)80105-2

17. Eroğlu S. How do we measure epicardial adipose tissue thickness by transthoracic echocardiography? Anatol J Cardiol. 2015; 15(5): 416-419. doi: 10.5152/akd.2015.5991

18. Bertaso AG, Bertol D, Duncan BB, Foppa M. Epicardial fat: Definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013; 101(1): e18-e28. doi: 10.5935/abc.20130138

19. Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018; 71(20): 2360-2372. doi: 10.1016/j.jacc.2018.03.509

20. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 2014; 20(1): 103-118. doi: 10.1016/j.cmet.2014.05.005

21. Fang W, Deng Z, Benadjaoud F, Yang D, Yang C, Shi GP. Regulatory T cells promote adipocyte beiging in subcutaneous adipose tissue. FASEB J. 2020; 34(7): 9755-9770. doi: 10.1096/fj.201902518R

22. Papotti B, Opstad TB, Åkra S, Tønnessen T, Braathen B, Hansen CH, et al. Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease. Front Cardiovasc Med. 2023; 10: 1055069. doi: 10.3389/fcvm.2023.1055069

23. Pinzon Grimaldos A, Bini S, Pacella I, Rossi A, Di Costanzo A, Minicocci I, et al. The role of lipid metabolism in shaping the expansion and the function of regulatory T cells. Clin Exp Immunol. 2022; 208(2): 181-192. doi: 10.1093/cei/uxab033

24. Filatova AYu, Potekhina AV, Ruleva NYu, Radyukhina NV, Arefieva TI. The influence of atorvastatin and rosuvastatin in atherosclerosis on the parameters of cellular immunity and in vitro leucocyte activation. Russian Journal of Cardiology. 2018; 23(8): 59-64. (In Russ.). doi: 10.15829/1560-4071-2018-8-59-64

25. Rodríguez-Perea AL, Rojas M, Velilla-Hernández PA. High concentrations of atorvastatin reduce in vitro function of conventional T and regulatory T cells. Clin Exp Immunol. 2019; 196(2): 237-248. doi: 10.1111/cei.13260

26. Seidah NG, Awan Z, Chrétien M, Mbikay M. PCSK9: A key modulator of cardiovascular health. Circ Res. 2014; 114(6): 1022- 1036. doi: 10.1161/CIRCRESAHA.114.301621

27. Frostegård J. The role of PCSK9 in inflammation, immunity, and autoimmune diseases. Expert Rev Clin Immunol. 2022; 18(1): 67-74. doi: 10.1080/1744666X.2022.2017281

28. Cho DH, Joo HJ, Kim MN, Lim DS, Shim WJ, Park SM. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome. Cardiovasc Diabetol. 2018; 17(1): 95. doi: 10.1186/s12933-018-0735-7

29. Everett BM, MacFadyen JG, Thuren T, Libby P, Glynn RJ, Ridker PM. Inhibition of interleukin-1β and reduction in atherothrombotic cardiovascular events in the CANTOS trial. J Am Coll Cardiol. 2020; 76(14): 1660-1670. doi: 10.1016/j.jacc.2020.08.011

30. Gritsenko OV, Chumakova GA, Trubina EV. The role of epicardial obesity in the development of left ventricular diastolic dysfunction. Kardiologiia. 2023; 63(7): 32-38. (In Russ.). doi: 10.18087/cardio.2023.7.n2120